GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.05 $2.79 Friday, 19th Apr 2024 FGEN stock ended at $1.15. This is 1.71% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 12.38% from a day low at $1.05 to a day high of $1.18.
90 days $0.775 $2.93
52 weeks $0.335 $20.44

Historical FibroGen prices

Date Open High Low Close Volume
2024-03-14 $2.04 $2.17 $1.92 $2.09 1 570 163
2024-03-13 $1.90 $2.18 $1.86 $2.00 3 059 212
2024-03-12 $1.80 $2.07 $1.76 $1.89 2 045 621
2024-03-11 $1.77 $1.84 $1.69 $1.71 488 146
2024-03-08 $1.84 $1.89 $1.75 $1.80 571 048
2024-03-07 $1.87 $1.94 $1.71 $1.79 1 120 389
2024-03-06 $1.95 $1.96 $1.84 $1.87 617 494
2024-03-05 $1.92 $1.98 $1.78 $1.93 1 256 828
2024-03-04 $1.86 $2.02 $1.78 $1.98 1 511 458
2024-03-01 $1.75 $1.90 $1.68 $1.83 1 460 042
2024-02-29 $2.04 $2.08 $1.68 $1.71 2 184 323
2024-02-28 $2.09 $2.11 $1.91 $1.99 1 378 533
2024-02-27 $1.61 $2.22 $1.58 $2.12 3 125 709
2024-02-26 $1.80 $1.90 $1.73 $1.85 1 282 037
2024-02-23 $1.85 $2.04 $1.80 $1.82 1 663 993
2024-02-22 $1.75 $1.92 $1.67 $1.89 1 587 917
2024-02-21 $1.77 $1.92 $1.70 $1.72 1 805 786
2024-02-20 $2.15 $2.24 $1.70 $1.80 2 958 043
2024-02-16 $2.14 $2.27 $1.97 $2.19 2 743 555
2024-02-15 $2.26 $2.27 $2.08 $2.15 1 526 920
2024-02-14 $2.22 $2.35 $2.02 $2.25 2 658 542
2024-02-13 $2.66 $2.66 $2.16 $2.17 4 152 305
2024-02-12 $2.75 $2.93 $2.60 $2.72 4 105 891
2024-02-09 $2.40 $2.88 $2.34 $2.73 4 553 917
2024-02-08 $2.16 $2.53 $2.08 $2.38 4 040 624
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT